Nasdaq

Helius Medical Technologies Announces Positive Results from PoNS Stroke Registrational Program Supporting Planned FDA Submission for Gait and Balance Therapy

Helius Medical Technologies, Inc. announced positive outcomes from its Portable Neuromodulation Stimulator (PoNS) Stroke Registrational Program (SRP), which supports a planned FDA submission for ...
Nasdaq

Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation

NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and ...
Pharmabiz

Bioness Medical’s PoNS System receives FDA 510(k) clearance to treat dynamic gait deficit due to chronic stroke symptoms

Bioness Medical, Inc. (Bioness), a global leader in functional electrical stimulation (FES) and advanced rehabilitation technologies, announced that the company's PoNS (Portable Neuromodulation ...
WAVY-TV

Helius Medical Technologies Announces Authorization from Health Canada to Market Portable Neuromodulation Stimulator (PoNS®) Device for the Treatment of Gait Deficit Due to ...

NEWTOWN, Pa., March 09, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for ...